Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ACHV Achieve Life Sciences Inc

4,39

0,035 (0,80%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:00:34

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
Von Jul 2024 bis Aug 2024

Click Here for more Achieve Life Sciences Charts.

Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
Von Aug 2023 bis Aug 2024

Click Here for more Achieve Life Sciences Charts.

News Achieve Life Sciences Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 13 August 2024 (1 Tag vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 13 August 2024 (1 Tag vor) • Edgar (US Regulatory)

Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
Dienstag 13 August 2024 (1 Tag vor) • GlobeNewswire Inc.

Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence
Mittwoch 31 Juli 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 29 Juli 2024 (2 Wochen vor) • Edgar (US Regulatory)

Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank
Montag 29 Juli 2024 (2 Wochen vor) • GlobeNewswire Inc.

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024
Donnerstag 25 Juli 2024 (3 Wochen vor) • GlobeNewswire Inc.

Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024
Dienstag 9 Juli 2024 (1 Monat vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Dienstag 9 Juli 2024 (1 Monat vor) • Edgar (US Regulatory)

Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes
Montag 1 Juli 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 6 Juni 2024 (2 Monate vor) • Edgar (US Regulatory)

Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
Mittwoch 29 Mai 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Achieve Life Sciences Inc News-Artikel

Euro vs US Dollar

Invesco QQQ Trust Series 1

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen